Are you Dr. Rutkowski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 28 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
875 Ellicott St
Buffalo, NY 14203Phone+1 716-632-1088Fax+1 716-632-7842- Is this information wrong?
Summary
- Dr. Piotr Rutkowski, MD is a board certified anesthesiologist in Buffalo, New York. He is currently licensed to practice medicine in New York, Florida, and Wisconsin. He is affiliated with KALEIDA Health.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Anesthesiology, 2010 - 2014
- Jagiellonian University Medical CollegeClass of 2010
Certifications & Licensure
- FL State Medical License 2022 - 2026
- NY State Medical License 2015 - 2026
- WI State Medical License 2011 - 2019
- American Board of Anesthesiology Anesthesiology
Clinical Trials
- Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 4 citationsA discrepancy between CT angiography and transesophageal echocardiographic measurements of the annular size affect long term survival following trans-catheter aortic v...Siddarth Singh, Piotr S. Rutkowski, Alexey N. Dyachkov, Vijay Iyer, Leili Pourafkari, Nader D. Nader> ;Journal of Cardiovascular and Thoracic Research. 2021 Aug 25
- 719 citationsFive-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.Caroline Robert, Jean J. Grob, Daniil Stroyakovskiy, Boguslawa Karaszewska, Axel Hauschild, Evgeny Levchenko, Vanna Chiarion Sileni, Jacob Schachter, Claus Garbe, Igor...> ;The New England Journal of Medicine. 2019 Jun 4
- Adjuvant Pembrolizumab Versus Placebo in Resected Stage III MelanomaNageatte Ibrahim, Piotr Rutkowski> ;The New England Journal of Medicine.
- Join now to see all
Press Mentions
- Moleculin Reports Third Quarter 2022 Financial Results and Provides Pipeline UpdateNovember 10th, 2022
- Immunotherapy Drug Benefits Patients with High-Risk Local MelanomasSeptember 18th, 2021
- Dermatology Today and Tomorrow: From Symptom Control to Targeted TherapyDecember 18th, 2018
Hospital Affiliations
- KALEIDA HealthBuffalo, New York